Kyushu University
Clinical trials sponsored by Kyushu University, explained in plain language.
-
New hope for kids with tough cancers: GAIA-102 trial launches
Disease control Recruiting nowThis early-stage trial tests a new drug called GAIA-102 in children whose neuroblastoma or other solid tumors have not responded to standard treatments. The study has four groups: GAIA-102 alone, or combined with other drugs like dinutuximab or nivolumab. The main goal is to chec…
Phase: PHASE1 • Sponsor: Kyushu University • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New hope for advanced stomach and pancreatic cancer patients with fluid in the belly
Disease control Recruiting nowThis study tests a new drug called GAIA-102, given alone or with another drug (pembrolizumab), for people with advanced stomach or pancreatic cancer that has spread and causes fluid buildup in the belly (malignant ascites). The first part checks safety and the best dose, and the …
Phase: PHASE1, PHASE2 • Sponsor: Kyushu University • Aim: Disease control
Last updated May 19, 2026 11:48 UTC